martes, 13 de julio de 2021

Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial | BMC Infectious Diseases | Full Text

Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial | BMC Infectious Diseases | Full Text

No hay comentarios:

Publicar un comentario